|
Volumn 21, Issue 1, 2013, Pages 146-152
|
Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase
|
Author keywords
Acetylcholinesterase; Alzheimer's disease; Coumarin derivatives; Dual binding site inhibitors; Selective cholinesterase inhibition
|
Indexed keywords
3 (1 BENZYLPIPERIDIN 4 YLOXY) 2 OXO 2H CHROMENE;
3 (1 BENZYLPIPERIDIN 4 YLOXY) 6 METHOXY 2 OXO 2H CHROMENE;
3 (1 BENZYLPIPERIDIN 4 YLOXY) 6,7 DIMETHOXY 2 OXO 2H CHROMENE;
3 (1 BENZYLPIPERIDIN 4 YLOXY) 7 METHOXY 2 OXO 2H CHROMENE;
6,7 DIMETHOXY 2 OXO 2H CHROMENE 3 CARBOXYLIC ACID (1 BENZYLPIPERIDIN 4 YL)ESTER;
6,7 DIMETHOXY 2 OXO 2H CHROMENE 3 CARBOXYLIC ACID (4 BENZYLPIPERAZIN 1 YL)AMIDE;
6,7 DIMETHOXY 2 OXO 2H CHROMENE 3 CARBOXYLIC ACID [2 (N BENZYL N METHYLAMINO)ETHYL]AMIDE;
6,7 DIMETHOXY 2 OXO 2H CHROMENE 3 CARBOXYLIC ACID [3 (N BENZYL N METHYLAMINO)PROPYL]AMIDE;
6,7 DIMETHOXY 2 OXO 2H CHROMENE 3 CARBOXYLIC ACID [4 (N BENZYL N METHYLAMINO)BUTYL]AMIDE;
6,7 DIMETHOXY 2 OXO 2H CHROMENE 3 CARBOXYLIC ACID N (1 BENZYLPIPERIDIN 1 YL)AMIDE;
ACETYLCHOLINESTERASE;
ALIPHATIC AMINE;
CHOLINESTERASE INHIBITOR;
COUMARIN;
COUMARIN ALKYLAMINE DERIVATIVE;
DONEPEZIL;
UNCLASSIFIED DRUG;
ARTICLE;
BIOLOGICAL ACTIVITY;
DRUG BINDING SITE;
DRUG DESIGN;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
ENZYME ACTIVE SITE;
ENZYME INHIBITION;
IC 50;
STRUCTURE ACTIVITY RELATION;
ACETYLCHOLINESTERASE;
ALZHEIMER DISEASE;
ANIMALS;
BINDING SITES;
BUTYRYLCHOLINESTERASE;
CATTLE;
CHOLINESTERASE INHIBITORS;
COUMARINS;
HORSES;
HUMANS;
|
EID: 84870943115
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2012.10.045 Document Type: Article |
Times cited : (89)
|
References (31)
|